BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 29063202)

  • 21. Herbal treatments for alleviating premenstrual symptoms: a systematic review.
    Dante G; Facchinetti F
    J Psychosom Obstet Gynaecol; 2011 Mar; 32(1):42-51. PubMed ID: 21171936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation.
    Ambrosini A; Di Lorenzo C; Coppola G; Pierelli F
    Acta Neurol Belg; 2013 Mar; 113(1):25-9. PubMed ID: 22791378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study.
    Momoeda M; Sasaki H; Tagashira E; Ogishima M; Takano Y; Ochiai K
    Adv Ther; 2014 Mar; 31(3):362-73. PubMed ID: 24604699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitex agnus castus: a systematic review of adverse events.
    Daniele C; Thompson Coon J; Pittler MH; Ernst E
    Drug Saf; 2005; 28(4):319-32. PubMed ID: 15783241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.
    Schellenberg R
    BMJ; 2001 Jan; 322(7279):134-7. PubMed ID: 11159568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-Analysis.
    Ooi SL; Watts S; McClean R; Pak SC
    J Womens Health (Larchmt); 2020 Feb; 29(2):262-278. PubMed ID: 31464546
    [No Abstract]   [Full Text] [Related]  

  • 27. [The premenstrual syndrome: effectiveness of Vitex agnus castus].
    Döll M
    Med Monatsschr Pharm; 2009 May; 32(5):186-91. PubMed ID: 19469189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the mu-opiate receptor by Vitex agnus-castus methanol extracts: implication for its use in PMS.
    Webster DE; Lu J; Chen SN; Farnsworth NR; Wang ZJ
    J Ethnopharmacol; 2006 Jun; 106(2):216-21. PubMed ID: 16439081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).
    Berger D; Schaffner W; Schrader E; Meier B; Brattström A
    Arch Gynecol Obstet; 2000 Nov; 264(3):150-3. PubMed ID: 11129515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Our experience with management of inherited thrombophilia during pregnancy. Preliminary report].
    Marinov B; Pramatarova T; Andreeva A; Larukova N; Slavov A
    Akush Ginekol (Sofiia); 2011; 50(6):18-20. PubMed ID: 22452062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
    Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
    Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitex agnus-castus safeguards the lung against lipopolysaccharide-induced toxicity in mice.
    Ibrahim SRM; Ahmed N; Almalki S; Alharbi N; El-Agamy DS; Alahmadi LA; Saubr MK; Elkablawy M; Elshafie RM; Mohamed GA; El-Kholy MA
    J Food Biochem; 2019 Mar; 43(3):e12750. PubMed ID: 31353538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacotherapeutic management of premenstrual dysphoric disorder.
    Ciccone N; Kovacheff MB; Frey BN
    Expert Opin Pharmacother; 2023 Jan; 24(1):145-151. PubMed ID: 35974667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorder in Adolescent Athletes.
    Czajkowska M; Drosdzol-Cop A; Gałązka I; Naworska B; Skrzypulec-Plinta V
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):492-8. PubMed ID: 26233292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of premenstrual syndrome and premenstrual dysphoric disorder with bulimia nervosa and binge-eating disorder in a nationally representative epidemiological sample.
    Nobles CJ; Thomas JJ; Valentine SE; Gerber MW; Vaewsorn AS; Marques L
    Int J Eat Disord; 2016 Jul; 49(7):641-50. PubMed ID: 27206163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are changes of prolactin levels the effectors of vitex agnus castus beneficial effects on the pre-menstrual syndrome?
    Tamagno G
    Maturitas; 2009 Aug; 63(4):369. PubMed ID: 19632795
    [No Abstract]   [Full Text] [Related]  

  • 38. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
    Yang J; Joe SH; Lee MS; Kim SH; Jung IK
    Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a role for Western herbal medicine in treating cyclic perimenstrual pain and discomfort?
    Fisher CY; Adams J; Frawley JE; Hickman LD; Sibbritt DW
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):154-156. PubMed ID: 30136281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.